Search Results - "Mi, Xiaojuan"

Trends in Settings for Peripheral Vascular Intervention and the Effect of Changes in the Outpatient Prospective Payment System by Jones, W. Schuyler, MD, Mi, Xiaojuan, PhD, Qualls, Laura G., MS, Vemulapalli, Sreekanth, MD, Peterson, Eric D., MD, MPH, Patel, Manesh R., MD, Curtis, Lesley H., PhD

“…Abstract Background Peripheral vascular intervention (PVI) is an effective treatment option for patients with peripheral artery disease (PAD). In 2008,…”
Get full text

Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study by Mi, Xiaojuan, Hammill, Bradley G., Curtis, Lesley H., Lai, Edward Chia-Cheng, Setoguchi, Soko

“…Observational comparative effectiveness and safety studies are often subject to immortal person‐time, a period of follow‐up during which outcomes cannot occur…”
Get full text

Implications of M Bias in Epidemiologic Studies: A Simulation Study by Liu, Wei, Brookhart, M. Alan, Schneeweiss, Sebastian, Mi, Xiaojuan, Setoguchi, Soko

“…Abstract Collider-stratification bias arises from conditioning on a variable (collider) which opens a path from exposure to outcome. M bias occurs when the…”
Get full text

Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction by Hernandez, Adrian F, Mi, Xiaojuan, Hammill, Bradley G, Hammill, Stephen C, Heidenreich, Paul A, Masoudi, Frederick A, Qualls, Laura G, Peterson, Eric D, Fonarow, Gregg C, Curtis, Lesley H

“…CONTEXT Aldosterone antagonist therapy for heart failure and reduced ejection fraction has been highly efficacious in randomized trials. However, questions…”
Get full text

Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: Findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM) by Wong, Yee Weng, MBBS, Fonarow, Gregg C., MD, Mi, Xiaojuan, PhD, Peacock, W. Frank, MD, Mills, Roger M., MD, Curtis, Lesley H., PhD, Qualls, Laura G., MS, Hernandez, Adrian F., MD, MHS

“…Background Timing of initial treatment for acute decompensated heart failure (ADHF) varies across hospitals and its impact on outcomes remains poorly defined…”
Get full text

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry by Nanna, Michael G., Navar, Ann Marie, Wang, Tracy Y., Mi, Xiaojuan, Virani, Salim S., Louie, Michael J., Lee, L. Veronica, Goldberg, Anne C., Roger, Veronique L., Robinson, Jennifer, Peterson, Eric D.

“…Background Current statin use and symptoms among older adults in routine community practice have not been well characterized since the release of the 2013…”
Get full text

Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure by Curtis, Lesley H., PhD, Mi, Xiaojuan, PhD, Qualls, Laura G., MS, Check, Devon K., BA, Hammill, Bradley G., MS, Hammill, Stephen C., MD, Heidenreich, Paul A., MD, Masoudi, Frederick A., MD, MSPH, Setoguchi, Soko, MD, DrPH, Hernandez, Adrian F., MD, MHS, Fonarow, Gregg C., MD

“…Background Aldosterone antagonist therapy is recommended for selected patients with heart failure and reduced ejection fraction. Adherence to therapy in the…”
Get full text

The Effect of Clinical Care Location on Clinical Outcomes After Peripheral Vascular Intervention in Medicare Beneficiaries by Turley, Ryan S., MD, Mi, Xiaojuan, PhD, Qualls, Laura G., MS, Vemulapalli, Sreekanth, MD, Peterson, Eric D., MD, MPH, Patel, Manesh R., MD, Curtis, Lesley H., PhD, Jones, W. Schuyler, MD

“…Abstract Objectives Modifications in reimbursement rates by Medicare in 2008 have led to peripheral vascular interventions (PVI) being performed more commonly…”
Get full text

Impact of immortal person-time and time scale in comparative effectiveness research for medical devices: a case for implantable cardioverter-defibrillators by Mi, Xiaojuan, Hammill, Bradley G, Curtis, Lesley H, Greiner, Melissa A, Setoguchi, Soko

“…Abstract Objectives To assess the extent of immortal time bias in estimating the clinical effectiveness of implantable cardioverter-defibrillators (ICDs) and…”
Get full text

Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry by DeVore, Adam D., MD, Mi, Xiaojuan, PhD, Mentz, Robert J., MD, Fonarow, Gregg C., MD, Van Dyke, Melissa K., PhD, MPH, Maya, Juan F., MD, MS, Hardy, N. Chantelle, MPH, Hammill, Bradley G., DrPH, Hernandez, Adrian F., MD, MHS

“…Background Elevated heart rate of ≥70 beats/min despite β-blocker use may represent a new treatment target in patients in sinus rhythm with heart failure with…”
Get full text

Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences by Navar, Ann Marie, Wang, Tracy Y, Mi, Xiaojuan, Robinson, Jennifer G, Virani, Salim S, Roger, Veronique L, Wilson, Peter W F, Goldberg, Anne C, Peterson, Eric D

“…Practice guidelines recommend that clinicians engage patients in treatment decisions and explain atherosclerotic cardiovascular disease (ASCVD) risk but do not…”
Get more information

Relation of Dyspnea Severity on Admission for Acute Heart Failure With Outcomes and Costs by Mentz, Robert J., MD, Mi, Xiaojuan, PhD, Sharma, Puza P., MBBS, MPH, PhD, Qualls, Laura G., MS, DeVore, Adam D., MD, Johnson, Katherine Waltman, PharmD, Fonarow, Gregg C., MD, Curtis, Lesley H., PhD, Hernandez, Adrian F., MD, MHS

“…Hospitalization for heart failure (HF) is frequently related to dyspnea, yet associations among dyspnea severity, outcomes, and health care costs are unknown…”
Get full text

Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF Trial by DeVore, Adam D, Mi, Xiaojuan, Thomas, Laine, Sharma, Puza P, Albert, Nancy M, Butler, Javed, Hernandez, Adrian F, Patterson, J Herbert, Spertus, John A, Williams, Fredonia B, Duffy, Carol I, McCague, Kevin, Fonarow, Gregg C

“…The US Food and Drug Administration approved sacubitril/valsartan for patients with chronic heart failure (HF) with reduced ejection fraction in 2015 on the…”
Get full text

Comparative Effectiveness of Cardiac Resynchronization Therapy With an Implantable Cardioverter-Defibrillator Versus Defibrillator Therapy Alone: A Cohort Study by MASOUDI, Frederick A, XIAOJUAN MI, QUALLS, Laura G, HERNANDEZ, Adrian F, CURTIS, Lesley H, PETERSON, Pamela N, CURTIS, Jeptha P, FONAROW, Gregg C, HAMMILL, Stephen C, HEIDENREICH, Paul A, AL-KHATIB, Sana M, PICCINI, Jonathan P

“…Trials comparing implantable cardioverter-defibrillator (ICD) therapy with cardiac resynchronization therapy with a defibrillator (CRT-D) are limited to…”
Get full text

Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine by Ford, Janet H., Ye, Wenyu, Ayer, David W., Mi, Xiaojuan, Bhandari, Swati, Buse, Dawn C., Lipton, Richard B.

“…Background No available studies demonstrate validity and meaningful change thresholds of Work Productivity and Activity Impairment (WPAI) questionnaire in…”
Get full text

Significant Variation in P2Y12 Inhibitor Use After Peripheral Vascular Intervention in Medicare Beneficiaries by Schuyler Jones, W., MD, Mi, Xiaojuan, PhD, Qualls, Laura G., MS, Turley, Ryan S., MD, Vemulapalli, Sreekanth, MD, Peterson, Eric D., MD, MPH, Patel, Manesh R., MD, Curtis, Lesley H., PhD

“…Abstract Background There is no consensus regarding whether to use antithrombotic medications in patients with peripheral artery disease (PAD) after…”
Get full text

Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia by Pokorney, Sean D., MD, MBA, Mi, Xiaojuan, PhD, Hammill, Bradley G., DrPH, Allen LaPointe, Nancy M., PharmD, MHS, Curtis, Lesley H., PhD, Al-Khatib, Sana M., MD, MHS

“…Ventricular tachycardia (VT) is common in cardiomyopathy patients with an implantable cardioverter-defibrillator. This analysis evaluated antiarrhythmic…”
Get full text

The Worst Symptom as Defined By Patients During Heart Failure Hospitalization: Implications for Response to Therapy by Kato, Mahoto, MD, Stevenson, Lynne W., MD, Palardy, Maryse, MD, Campbell, Patricia M., MD, May, Christopher W., MD, Lakdawala, Neal K., MD, Stewart, Garrick, MD, Nohria, Anju, MD, Rogers, Joseph G., MD, Heywood, J. Thomas, MD, Gheorghiade, Mihai, MD, Lewis, Eldrin F., MD, Mi, Xiaojuan, PhD, Setoguchi, Soko, MD, DrPH

“…Abstract Background Patients perceive different symptoms of heart failure decompensation. It is not known whether the nature of the worst symptom relates to…”
Get full text

Methodological Considerations in Observational Comparative Effectiveness Research for Implantable Medical Devices: An Epidemiologic Perspective by JALBERT, Jessica J, RITCHEY, Mary Elizabeth, XIAOJUAN MI, CHEN, Chih-Ying, HAMMILL, Bradley G, CURTIS, Lesley H, SETOGUCHI, Soko

“…Medical devices play a vital role in diagnosing, treating, and preventing diseases and are an integral part of the health-care system. Many devices, including…”
Get full text

Pharmacotherapy in Medicare beneficiaries with atrial fibrillation by Piccini, Jonathan P., MD, MHS, Mi, Xiaojuan, PhD, DeWald, Tracy A., PharmD, Go, Alan S., MD, Hernandez, Adrian F., MD, MHS, Curtis, Lesley H., PhD

“…Background There are limited data regarding national patterns of pharmacotherapy for atrial fibrillation (AF) among older patients. Drug exposure data are now…”
Get full text